Two Sigma Securities LLC Makes New Investment in Agilent Technologies, Inc. $A

Key Points

• Two Sigma Securities purchased 13,308 Agilent Technologies shares during the second quarter, valued at approximately $1.77 million. Several other institutional investors also initiated or expanded positions.
• Agilent exceeded quarterly expectations with $1.62 in EPS and $1.88 billion in revenue, while revenue increased 8.1% year over year. The company issued fiscal 2026 EPS guidance of $6.18–$6.21.
• Analysts remain broadly optimistic, with a “Moderate Buy” consensus and an average price target of $170.33; several firms recently raised targets to $175–$190. Shares were trading near $154.47, at roughly 30 times earnings.

Two Sigma Securities LLC purchased a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 13,308 shares of the medical research company's stock, valued at approximately $1,768,000.

A number of other hedge funds have also recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock worth $82,712,000 after purchasing an additional 24,687 shares in the last quarter. Bank of Nova Scotia bought a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $58,539,000. Dudley & Shanley Inc. boosted its stake in shares of Agilent Technologies by 25.9% in the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock worth $9,232,000 after buying an additional 14,300 shares during the last quarter. BIP Wealth LLC purchased a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $834,000. Finally, Crossmark Global Holdings Inc. grew its holdings in shares of Agilent Technologies by 39.6% in the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company's stock valued at $4,615,000 after acquiring an additional 9,615 shares in the last quarter.

Wall Street Analyst Weigh In

A number of analysts recently commented on A shares. JPMorgan Chase & Co. increased their price target on Agilent Technologies from $180.00 to $190.00 and gave the company an "overweight" rating in a research report on Thursday. Royal Bank Of Canada raised their target price on Agilent Technologies from $155.00 to $185.00 and gave the company an "outperform" rating in a research report on Thursday. Barclays increased their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an "overweight" rating in a research report on Thursday. Jefferies Financial Group started coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a "hold" rating and a $135.00 price objective on the stock. Finally, Morgan Stanley boosted their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $170.33.

Agilent Technologies Trading Up 0.4%

Shares of A opened at $154.47 on Monday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75. The business has a 50-day moving average of $140.30 and a 200 day moving average of $127.04. The firm has a market cap of $43.63 billion, a P/E ratio of 30.41, a price-to-earnings-growth ratio of 2.34 and a beta of 1.25. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company's revenue was up 8.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source